{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T23:56:24Z","timestamp":1780358184135,"version":"3.54.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T00:00:00Z","timestamp":1678838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T00:00:00Z","timestamp":1678838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"DOI":"10.1007\/s11547-023-01615-8","type":"journal-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T16:02:44Z","timestamp":1678896164000},"page":"492-500","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy and toxicity of infradiaphragmal radiotherapy fields in lymphoma patients: a single-centre experience"],"prefix":"10.1007","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2840-5734","authenticated-orcid":false,"given":"Lea","family":"Galunic Bilic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedor","family":"Santek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josip J.","family":"Grah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Basic-Kinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Mandac Smoljanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slobodanka","family":"Ostojic Kolonic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdravko","family":"Mitrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijo","family":"Vodanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dino","family":"Dujmovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Aurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,15]]},"reference":[{"key":"1615_CR1","doi-asserted-by":"publisher","DOI":"10.1201\/b15450","volume-title":"Basic clinical radiobiology","author":"M Joiner","year":"2009","unstructured":"Joiner M, Kogel A (2009) Basic clinical radiobiology, 4th edn. CRC Press, Abingdon, Oxon","edition":"4"},{"key":"1615_CR2","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ijrobp.2013.02.007","volume":"86","author":"Z Shi","year":"2013","unstructured":"Shi Z, Das S, Okwan-Doudu D, Esiashvili N, Flowers C, Chen Z, Wang X, Jiang K, Nastoupil JL, Khan KM (2013) Patterns of failure in advanced stage diffuse large B cell lymphoma after complete response to R-CHOP immunochemotherapy and the emerging role of consolidative radiation therapy. Int J Radiat Oncol Biol Phys 86:569\u2013577","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"1615_CR3","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1200\/JCO.2013.51.4505","volume":"32","author":"G Held","year":"2014","unstructured":"Held G, Murawski N, Ziepert M, Fleckenstein J, Pochel V, Zwick C et al (2014) Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma. J Clin Oncol 32(11):1112\u20131118. https:\/\/doi.org\/10.1200\/JCO.2013.51.4505","journal-title":"J Clin Oncol"},{"issue":"9","key":"1615_CR4","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1200\/JCO.1989.7.9.1179","volume":"7","author":"DL Longo","year":"1989","unstructured":"Longo DL (1989) Combined modality therapy for localized aggressive lymphoma: enough or too much? J Clin Oncol 7(9):1179\u20131181. https:\/\/doi.org\/10.1200\/JCO.1989.7.9.1179","journal-title":"J Clin Oncol"},{"issue":"1","key":"1615_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11864-015-0377-x","volume":"17","author":"L Specht","year":"2016","unstructured":"Specht L (2016) Does radiation have a role in advanced stage hodgkin\u2019s or Non-Hodgkin lymphoma? Curr Treat Options Oncol 17(1):4. https:\/\/doi.org\/10.1007\/s11864-015-0377-x","journal-title":"Curr Treat Options Oncol"},{"issue":"4","key":"1615_CR6","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.ijrobp.2021.06.030","volume":"111","author":"SA Milgrom","year":"2021","unstructured":"Milgrom SA, Bakst RL, Campbell BA (2021) Clinical outcomes confirm conjecture: modern radiation therapy reduces the risk of late toxicity in survivors of Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 111(4):841\u2013850. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.06.030","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1615_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ijrobp.2016.10.004","volume":"97","author":"JL Conway","year":"2017","unstructured":"Conway JL, Connors JM, Tyldesley S et al (2017) Secondary breast cancer risk by radiation volume in women with Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 97(1):35\u201341. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.10.004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1615_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1200\/JCO.2015.63.4444","volume":"34","author":"FA van Nimwegen","year":"2016","unstructured":"van Nimwegen FA, Schaapveld M, Cutter DJ et al (2016) Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma. J Clin Oncol 34(3):235\u2013243. https:\/\/doi.org\/10.1200\/JCO.2015.63.4444","journal-title":"J Clin Oncol"},{"key":"1615_CR9","doi-asserted-by":"publisher","first-page":"8033","DOI":"10.2147\/OTT.S220730","volume":"12","author":"U Ricardi","year":"2019","unstructured":"Ricardi U, Maraldo MV, Levis M, Parkih RR (2019) Proton therapy For lymphomas: current state of the art. Onco Targets Ther 12:8033\u20138046. https:\/\/doi.org\/10.2147\/OTT.S220730","journal-title":"Onco Targets Ther"},{"key":"1615_CR10","doi-asserted-by":"publisher","first-page":"103326","DOI":"10.1016\/j.critrevonc.2021.103326","volume":"161","author":"GC Iorio","year":"2021","unstructured":"Iorio GC, Salvestrini V, Borghetti P et al (2021) The impact of modern radiotherapy on radiation-induced late sequelae: focus on early-stage mediastinal classical Hodgkin lymphoma a critical review by the young group of the italian association of radiotherapy and clinical oncology (AIRO). Crit Rev Oncol Hematol. 161:103326. https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103326","journal-title":"Crit Rev Oncol Hematol."},{"key":"1615_CR11","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.ijrobp.2011.12.067","volume":"84","author":"JA Dorth","year":"2012","unstructured":"Dorth JA, Prosnitz LR, Broadwater G, Diehl LF, Beaven AW, Coleman RE, Kelsay CR (2012) Impact of consolidation radiation therapy in stage III-IV diffuse large B-cell lymphoma with negative post-chemotherapy radiologic imaging. Int J Radiat Oncol Biol Phys 84:762\u2013767","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1615_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ijrobp.2014.01.006","volume":"98","author":"T Illidge","year":"2014","unstructured":"Illidge T, Specht L, Yahalom J, Aleman B, Berthelsen AK, Constine L, Dabaja B et al (2014) Modern radiation therapy for nodal non-Hodgkin lymphoma- target definition and dose guidelines from the international lymphoma oncology group. Int J Radiat Oncol Biol Phys 98:49\u201358","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1615_CR13","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1600-0609.1988.tb00847.x","volume":"40","author":"L Specht","year":"1988","unstructured":"Specht L, Nissen NI (1988) Hodgkin\u2019s disease stages I and II with infradiaphragmatic presentation: a rare and prognostically unfavorable combination. Eur J Haematol 40:396\u2013402","journal-title":"Eur J Haematol"},{"key":"1615_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0360-3016(01)01813-2","volume":"52","author":"MC Hull","year":"2002","unstructured":"Hull MC, Mendenhall NP, Colgan ME (2002) Subdiaphragmatic hodgkin\u2019s disease: the University of Florida experiance. Int J Rad Oncol Biol Phys 52:161\u2013166","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"1615_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4103\/0973-1482.37406","volume":"3","author":"R Akoum","year":"2007","unstructured":"Akoum R, Brihi E, Saade M, Hanna T, Chahine G (2007) Salvage abdominal irradiation for refractory non-Hodgkin\u2019s lymphoma. J Can Res Ther 3:143\u2013149. https:\/\/doi.org\/10.4103\/0973-1482.37406","journal-title":"J Can Res Ther"},{"key":"1615_CR16","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/S0161-5890(03)00080-4","volume":"39","author":"E Brihi","year":"2003","unstructured":"Brihi E, Akoum R, Saade M, Chanine G (2003) Abdominal irradiation after chemotherapy in non-Hodgkin\u2019s lymphoma: review of 32 patients. Mol Immunol 39:1121\u20131128","journal-title":"Mol Immunol"},{"key":"1615_CR17","first-page":"391","volume":"14","author":"JH Glick","year":"1995","unstructured":"Glick JH, Kim K, Earle J et al (1995) An ECOG randomized phase III trial of CHOP vs CHOP plus radiotherapy for intermediate grade early stage NHL. Proc Am Soc Clin Oncol. 14:391","journal-title":"Proc Am Soc Clin Oncol."},{"key":"1615_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJM199807023390104","volume":"339","author":"TP Miller","year":"1998","unstructured":"Miller TP, Dahlberg S, Cassady JR et al (1998) Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin\u2019s lymphoma. N Engl J Med 339:21\u201326","journal-title":"N Engl J Med"},{"issue":"12","key":"1615_CR19","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1056\/NEJMoa042040","volume":"352","author":"F Reyes","year":"2005","unstructured":"Reyes F, Lepage E, Ganem G, Molina TJ, Brice P, Coiffier B, Morel P, Ferme C, Bosly A, Lederlin P, Laurent G, Tilly H (2005) Groupe d\u2019Etude des lymphomes de l\u2019Adulte (GELA) ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma. N Engl J Med. 352(12):1197\u2013205. https:\/\/doi.org\/10.1056\/NEJMoa042040","journal-title":"N Engl J Med."},{"key":"1615_CR20","doi-asserted-by":"crossref","first-page":"a724","DOI":"10.1182\/blood.V98.3.705","volume":"98","author":"T Miller","year":"2001","unstructured":"Miller T, Leblanc M, Spier C et al (2001) CHOP alone compared with CHOP plus radiotherapy for early stage aggressive non-Hodgkin\u2019s lymphomas: update of the Southwest Oncology Group (SWOG) Randomized trial. Blood. 98:a724","journal-title":"Blood."},{"key":"1615_CR21","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/0360-3016(94)90352-2","volume":"30","author":"A Aviles","year":"1994","unstructured":"Aviles A, Delgado S, Nambo MJ, Alatriste S, Dias-Maqueo JC (1994) Adjuvant radiotherapy to sites of previous bulky disease in patients stage IV diffuse large cell lymphoma. Int J Radiat Oncol Biol Phys 30:799\u2013803","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1615_CR22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1159\/000012104","volume":"58","author":"AJ Ferreri","year":"2000","unstructured":"Ferreri AJ, Dell\u2019Oro S, Reni M, Ceresoli GL, Cozzarini C, Ponzoni M, Villa E (2000) Consolidation radiotherapy to bulky or semibulky lesions in the management of stage III-IV diffuse large B cell lymphomas. Oncology 58:219\u2013226. https:\/\/doi.org\/10.1159\/000012104","journal-title":"Oncology"},{"key":"1615_CR23","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1200\/JCO.2015.61.7654","volume":"33","author":"JA Vargo","year":"2015","unstructured":"Vargo JA, Gill BS, Balasubramani GK, Beriwal S (2015) Treatment selection and survival outcomes in early-stage diffuse-large B-cell lymphoma: do we still need consolidative radiotherapy? J Clin Oncol 33:3710\u20133717. https:\/\/doi.org\/10.1200\/JCO.2015.61.7654","journal-title":"J Clin Oncol"},{"key":"1615_CR24","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1200\/JCO.2009.27.3441","volume":"28","author":"J Phan","year":"2010","unstructured":"Phan J, Mazloom A, Medeiros LJ, Zreik TG, Wogan C, Shihadeh F et al (2010) Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy. J Clin Oncol 28:4170\u20134176. https:\/\/doi.org\/10.1200\/JCO.2009.27.3441","journal-title":"J Clin Oncol"},{"key":"1615_CR25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/bjh.12878","volume":"166","author":"GA Follows","year":"2014","unstructured":"Follows GA, Ardeshna KM, Barrington SF et al (2014) Guidelines for the first line management of classical Hodgkin lymphoma. Br J Haematol. 166:34\u201339. https:\/\/doi.org\/10.1111\/bjh.12878","journal-title":"Br J Haematol."},{"issue":"4","key":"1615_CR26","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1148\/81.4.632","volume":"81","author":"L Delclos","year":"1963","unstructured":"Delclos L, Braun E J, Raul Herrera J (1963) Whole Abdominal irradiation by Cobalt-60Moving-Strip Technic. Radiology 81(4):632\u2013641","journal-title":"Radiology"},{"key":"1615_CR27","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1200\/JCO.1988.6.12.1832","volume":"6","author":"A Surbone","year":"1988","unstructured":"Surbone A, Longo DL, DeVita VT Jr, Ihde DC, Duffey PL et al (1988) Residual abdominal masses in aggressive non-Hodgkin\u2019s lymphoma after combination chemotherapy: significance and management. J Clin Oncol 6:1832\u20131837. https:\/\/doi.org\/10.1200\/JCO.1988.6.12.1832","journal-title":"J Clin Oncol"},{"key":"1615_CR28","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s00066-016-0992-x","volume":"192","author":"K Elsayad","year":"2015","unstructured":"Elsayad K, Eich HT (2015) Survival benefit by consolidating Radiotherapy in patients with diffuse large B-Cell lymphoma in early stages. Strahlenther Oncol 192:502\u2013504. https:\/\/doi.org\/10.1007\/s00066-016-0992-x","journal-title":"Strahlenther Oncol"},{"issue":"15","key":"1615_CR29","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1200\/JCO.2004.06.088","volume":"22","author":"SJ Horning","year":"2004","unstructured":"Horning SJ, Weller E, Kim K, Earle JD, O\u2019Connell MJ, Habermann TM, Glick JH (2004) Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin\u2019s lymphoma: EASTERN cooperative oncology group study 1484. J Clin Oncol 22(15):3032\u20133038. https:\/\/doi.org\/10.1200\/JCO.2004.06.088","journal-title":"J Clin Oncol"},{"issue":"3","key":"1615_CR30","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/PPO.0000000000000453","volume":"26","author":"BS Imber","year":"2020","unstructured":"Imber BS, Yahalom J (2020) Radiotherapy for non-Hodgkin lymphomas. Cancer J 26(3):217\u2013230. https:\/\/doi.org\/10.1097\/PPO.0000000000000453","journal-title":"Cancer J"},{"issue":"1","key":"1615_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.clml.2016.09.008","volume":"17","author":"M Levis","year":"2017","unstructured":"Levis M, Piva C, Filippi AR et al (2017) Potential benefit of involved-field radiotherapy for patients with relapsed-refractory Hodgkin\u2019s lymphoma with incomplete response before autologous stem cell transplantation. Clin Lymphoma Myeloma Leuk 17(1):14\u201322. https:\/\/doi.org\/10.1016\/j.clml.2016.09.008","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"1615_CR32","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/s0360-3016(97)00352-0","volume":"39","author":"A Wirth","year":"1997","unstructured":"Wirth A, Corry J, Laidlaw C, Matthews J, Liew KH (1997) Salvage radiotherapy for Hodgkin\u2019s disease following chemotherapy failure. Int J Radiat Oncol Biol Phys 39:599\u2013607. https:\/\/doi.org\/10.1016\/s0360-3016(97)00352-0","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"1615_CR33","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.ijrobp.2018.01.011","volume":"100","author":"LS Constine","year":"2018","unstructured":"Constine LS, Yahalom J, Ng AK, Hodgson DC, Wirth A, Milgrom SA, Mikhaeel MG et al (2018) The role of radiation therapy in patients with relapsed or refractory Hodgkin lymphoma: guidelines from the international lymphoma radiation oncology group. Int J Radiat Oncol Biol Phys 100(5):1100\u20131118. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.01.011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1615_CR34","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ijrobp.2010.05.010","volume":"81","author":"S Kahn","year":"2011","unstructured":"Kahn S, Flowers C, Xu Z, Esiashvili N (2011) Does the addition of involved field radiotherapy to high-dose chemotherapy and stem cell transplantation improve outcomes for patients with relapsed\/refractory Hodgkin lymphoma? Int J Radat Oncol Biol Phys 81(1):175\u2013180. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.05.010","journal-title":"Int J Radat Oncol Biol Phys"},{"key":"1615_CR35","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1002\/cncr.25117","volume":"116","author":"BA Campbell","year":"2010","unstructured":"Campbell BA, Voss N, Woods R, Gascoyne RD, Morris R, Pickles T et al (2010) Long-term outcomes for patients with limited stage follicular lymphoma: involved regional radiotherapy versus involved node radiotherapy. Cancer. 116:3797\u2013806. https:\/\/doi.org\/10.1002\/cncr.25117","journal-title":"Cancer."},{"key":"1615_CR36","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.radonc.2011.05.013","volume":"100","author":"L Lowry","year":"2011","unstructured":"Lowry L, Smith P, Qian W, Falk S, Benstead K, Illidge T et al (2011) Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: randomised phase III trial. Radiother Oncol. 100:86\u201392. https:\/\/doi.org\/10.1016\/j.radonc.2011.05.013","journal-title":"Radiother Oncol."},{"issue":"3","key":"1615_CR37","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1182\/blood-2018-04-843540","volume":"133","author":"JL Brady","year":"2019","unstructured":"Brady JL, Binkley MS, Hajj C, Chelius M, Chau K, Balogh A et al (2019) Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG. Blood 133(3):237\u2013245. https:\/\/doi.org\/10.1182\/blood-2018-04-843540","journal-title":"Blood"},{"key":"1615_CR38","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1002\/cncr.25149","volume":"116","author":"TJ Pugh","year":"2010","unstructured":"Pugh TJ, Ballonoff P, Newman F, Rabinovitch R (2010) Improved survival with patients with early stage low-grade follicular lymohoma treated with radiation: a surveilance, epidemiology and end results database analysis. Cancer. 116:3843\u201351. https:\/\/doi.org\/10.1002\/cncr.25149","journal-title":"Cancer."},{"key":"1615_CR39","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s00277-003-0655-8","volume":"82","author":"RL Haas","year":"2003","unstructured":"Haas RL, Girinsky T (2003) HOVON 47\/EORTC 20013: chlorambucil vs 2x2 Gy involved field radiotherapy in stage III\/IV previously untreated follicular lymphoma patients. Ann Hematol 82:458\u2013462","journal-title":"Ann Hematol"},{"issue":"3","key":"1615_CR40","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S1470-2045(20)30686-0","volume":"22","author":"P Hoskin","year":"2021","unstructured":"Hoskin P, Popova B, Schofield O, Brammer C, Robinson M, Brunt AM, Madhavan K, Illidge T, Gallop-Evans E, Syndikus I, Clifton-Hadley L, Kirkwood AA (2021) 4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial. Lancet Oncol 22(3):332\u2013340. https:\/\/doi.org\/10.1016\/S1470-2045(20)30686-0. (Epub 2021 Feb 1 PMID: 33539729)","journal-title":"Lancet Oncol"},{"key":"1615_CR41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ijrobp.2012.12.024","volume":"86","author":"AL Russo","year":"2013","unstructured":"Russo AL, Chen YH, Martin NE, Vinjamoori A, Luthky SK, Freedman A et al (2013) Low-dose involved-field radiation in the treatment of non-Hodgkin lymphoma: predictors of response and treatment failure. Int J Radiat Oncol Biol Phys. 86:121\u20137. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.12.024","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"1615_CR42","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1200\/JCO.2003.09.542","volume":"21","author":"RL Haas","year":"2003","unstructured":"Haas RL, Poortmans P, de Jong D, Aleman BM, Dewit LG, Verheij M et al (2003) High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas. J Clin Oncol 21:2474\u20132480. https:\/\/doi.org\/10.1200\/JCO.2003.09.542","journal-title":"J Clin Oncol"},{"key":"1615_CR43","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1148\/radiology.192.2.8029434","volume":"192","author":"RK Valicenti","year":"1994","unstructured":"Valicenti RK, Wasserman TH, Monyak DJ, Kucik NA (1994) Non-hodgkin\u2019s lymphoma: whole-abdomen irradiation as an adjuvant to chemotherapy. Radiology 192:571\u2013576. https:\/\/doi.org\/10.1148\/radiology.192.2.8029434","journal-title":"Radiology"},{"key":"1615_CR44","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1002\/1097-0142(197606)37:6<2797::AID-CNCR2820370635>3.0.CO;2-H","volume":"37","author":"R Goffinet","year":"1976","unstructured":"Goffinet R, Glatstein E, Fuks Z, Kaplan HS (1976) Abdominal irradiation in non-Hodgkin\u2019s lymphoma. Cancer 37:2797\u20132806","journal-title":"Cancer"},{"key":"1615_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0360-3016(88)90343-4","volume":"15","author":"LR Coia","year":"1987","unstructured":"Coia LR, Hanks GE (1987) Complications from large field intermediate dose infradiaphragmatic radiation: an analysis of the patterns of care outcome studies for Hodgkin\u2019s disease and seminoma. Int J Rad Oncol Biol Phys 15:29\u201335","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"1615_CR46","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/0360-3016(93)90156-P","volume":"25","author":"A Niemierko","year":"1993","unstructured":"Niemierko A, Goitein M (1993) Modeling of normal tissue response to radiation: the critical volume model. Int J Radiot Oncol Biol Phys 25:134\u2013145","journal-title":"Int J Radiot Oncol Biol Phys"},{"key":"1615_CR47","first-page":"554","volume":"57","author":"L Galuni\u0107 Bili\u0107","year":"2018","unstructured":"Galuni\u0107 Bili\u0107 L, \u0160antek F (2018) Infradiaphragmal radiotherapy in patients with Lymphoma volume definition and side effects. Acta clinica Croatica. 57:554\u2013560","journal-title":"Acta clinica Croatica."},{"key":"1615_CR48","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0167-8140(84)80044-4","volume":"2","author":"D Gallez-Marchal","year":"1984","unstructured":"Gallez-Marchal D, Fayolle M, Henry-Amar M, LeBourgeois JP, Rougier P, Cosset JM (1984) Radiation injuries of the gastrointestinal tract in Hodgkin\u2019s disease: The role of exploratory laparotomy and fractionation. Radiother Oncol 2:93\u201399","journal-title":"Radiother Oncol"},{"key":"1615_CR49","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0167-8140(85)80041-4","volume":"3","author":"D Langlios","year":"1985","unstructured":"Langlios D, LeBourgeois JP, Leung S, Keuentz M (1985) Intestinal complications of wide field abdominal irradiation for lymphoma. Radiother Onkol 3:293\u2013298","journal-title":"Radiother Onkol"},{"key":"1615_CR50","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/s0360-3016(98)00034-0","volume":"41","author":"MA Mah\u00e9","year":"1998","unstructured":"Mah\u00e9 MA, Bourdin S, Le Mevel A, Moreau P, Moreau A, Hamidou M, Gaillard F, Rapp MJ, Milpied N, Harousseau JL (1998) Long-term results of total abdominopelvic irradiation in non-Hodgkin\u2019s lymphomas after failure of chemotherapy. Int J Radiat Oncol Biol Phys 41:117\u2013121. https:\/\/doi.org\/10.1016\/s0360-3016(98)00034-0","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1615_CR51","volume-title":"Hodgkin\u2019s Disease","author":"HS Kaplan","year":"1980","unstructured":"Kaplan HS (1980) Hodgkin\u2019s Disease, 2nd edn. MA, Harvard University Press, Boston","edition":"2"},{"key":"1615_CR52","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ijrobp.2009.02.089","volume":"76","author":"LA Dawson","year":"2010","unstructured":"Dawson LA, Kavanagh BD, Paulino AC et al (2010) Radiation-Associated Kidney Injury. Int J Radiat Oncol Biol Phys 76:108\u2013115","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1615_CR53","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.radonc.2015.10.022","volume":"118","author":"RR Parikh","year":"2016","unstructured":"Parikh RR, Grossbard ML, Harrison LB, Yahalom J (2016) Association of intensity-modulated radiation therapy on overall survival for patients with Hodgkin lymphoma. Radiother Oncol. 118:52\u201359","journal-title":"Radiother Oncol."},{"issue":"Suppl 1","key":"1615_CR54","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.3346\/jkms.2016.31.S1.S75","volume":"31","author":"WH Choi","year":"2016","unstructured":"Choi WH, Cho J (2016) Evolving clinical cancer radiotherapy: concerns regarding normal tissue protection and quality assurance. J Korean Med Sci 31(Suppl 1):S75\u2013S87","journal-title":"J Korean Med Sci"},{"issue":"1","key":"1615_CR55","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ijrobp.2016.10.004","volume":"97","author":"JL Conway","year":"2017","unstructured":"Conway JL, Connors JM, Tyldesley S, Savage KJ, Campbell BA, Zheng YY, Hamm J, Pickles T (2017) Secondary breast cancer risk by Radiation volume in women with Hodgkin Lymphoma. Int J Radiat Oncol Biol Phys 97(1):35\u201341. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.10.004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"20","key":"1615_CR56","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1200\/JCO.20.01186","volume":"39","author":"KC Oeffinger","year":"2021","unstructured":"Oeffinger KC, Stratton KL, Hudson MM, Leisenring WM, Henderson TO et al (2021) Impact of risk-adapted therapy for pediatric Hodgkin Lymphoma on risk of long-term morbidity: a report from the childhood cancer Survivor study. J Clin Oncol 39(20):2266\u20132275. https:\/\/doi.org\/10.1200\/JCO.20.01186","journal-title":"J Clin Oncol"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-023-01615-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11547-023-01615-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-023-01615-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T13:53:09Z","timestamp":1681998789000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11547-023-01615-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,15]]},"references-count":56,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["1615"],"URL":"https:\/\/doi.org\/10.1007\/s11547-023-01615-8","relation":{},"ISSN":["1826-6983"],"issn-type":[{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,15]]},"assertion":[{"value":"9 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This was a retrospective study using anonymized patient data, performed in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Ethics Committees of our institution and Medical School.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}